Inhibition of tumor angiogenesis by interferon-γ by suppression of tumor-associated macrophage differentiation

Oncology Research

Volumn 21, Issue 5, 2013, Pages 227-235

  Sun, Tao ^a   Yang, Ye ^a   Luo, Xiaoguang ^a   Cheng, Ying ^a   Zhang, Mingyu ^a   Wang, Kun ^a   Ge, Chunlin ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Angiogenesis; Gallbladder cancer; Immunotherapy; Interferon (IFN ); Tumor associated macrophages (TAMs)

Indexed keywords

CD14 ANTIGEN; CD34 ANTIGEN; RECOMBINANT GAMMA INTERFERON; VASCULOTROPIN; GAMMA INTERFERON; RECOMBINANT PROTEIN; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CAPILLARY DENSITY; CELL DIFFERENTIATION; CELL INFILTRATION; CONTROLLED STUDY; GALLBLADDER CANCER; GALLBLADDER CANCER CELL LINE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MICROVASCULATURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL RATE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR MICROENVIRONMENT; ANIMAL; BAGG ALBINO MOUSE; DISEASE COURSE; DRUG EFFECTS; DRUG SCREENING; GALLBLADDER NEOPLASMS; MACROPHAGE; METABOLISM; MONOCYTE; NEOVASCULARIZATION, PATHOLOGIC; NUDE MOUSE; PATHOLOGY; RANDOMIZATION; TUMOR CELL LINE; VASCULARIZATION;

ANIMALS; CELL DIFFERENTIATION; CELL LINE, TUMOR; DISEASE PROGRESSION; GALLBLADDER NEOPLASMS; HUMANS; INTERFERON-GAMMA; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MONOCYTES; NEOVASCULARIZATION, PATHOLOGIC; RANDOM ALLOCATION; RECOMBINANT PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84911094375     PISSN: 09650407     EISSN: 15553906     Source Type: Journal    
DOI: 10.3727/096504014X13890370410285     Document Type: Article

References (41)

1. Mantovani, A.; Sozzani, S.; Locati, M.; Allavena, P.; Sica, A. Macrophage polarization: Tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23:549-555; 2002.
2. DeNardo, D. G.; Barreto, J. B.; Andreu, P.; Vasquez, L.; Tawfik, D.; Kolhatkar, N.; Coussens, L. M. CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell 16(2):91-102; 2009.
3. Mantovani, A.; Sica, A.; Sozzani, S.; Allavena, P.; Vecchi, A.; Locati, M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25(12):677-786; 2004.
4. Gordon, S.; Taylor, P. R. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5(12):953-964; 2005.
5. Allavena, P.; Sica, A.; Solinas, G.; Porta, C.; Mantovani, A. The inflammatory micro-environment in tumor progression: The role of tumor-associated macrophages. Crit. Rev. Oncol. Hematol. 66(1):1-9; 2008.
6. Ohno, S.; Inagawa, H.; Dhar, D. K.; Fujii, T.; Ueda, S.; Tachibana, M.; Ohno, Y.; Suzuki, N.; Inoue, M.; Soma, G.; Nagasue, N. Role of tumor-associated macrophages (TAM) in advanced gastric carcinoma: The impact on FasL-mediated counterattack. Anticancer Res. 25(1B):463-470; 2005.
7. Zeni, E.; Mazzetti, L.; Miotto, D.; Lo Cascio, N.; Maestrelli, P.; Querzoli, P.; Pedriali, M.; De Rosa, E.; Fabbri, L. M.; Mapp, C. E.; Boschetto, P. Macrophage expression of interleukin-10 is a prognostic factor in nonsmall cell lung cancer. Eur. Respir. J. 30(4):627-632; 2007.
8. Murri, A. M.; Hilmy, M.; Bell, J.; Wilson, C.; McNicol, A. M.; Lannigan, A.; Doughty, J. C.; McMillan, D. C. The relationship between the systemic inflammatory response, tumour proliferative activity, T-lymphocytic and macrophage infiltration, microvessel density and survival in patients with primary operable breast cancer. Br. J. Cancer 99(7):1013-1019; 2008.
9. Laoui, D.; Movahedi, K.; Van Overmeire, E.; Van den Bossche, J.; Schouppe, E.; Mommer, C.; Nikolaou, A.; Morias, Y.; De Baetselier, P.; Van Ginderachter, J. A. Tumorassociated macrophages in breast cancer: Distinct subsets, distinct functions. Int. J. Dev. Biol. 55(7-9):861-867; 2011.
10. Wu, H.; Xu, J. B.; He, Y. L.; Peng, J. J.; Zhang, X. H.; Chen, C. Q.; Li, W.; Cai, S. R. Tumor-associated macrophages promote angiogenesis and lymphangiogenesis of gastric cancer. J. Surg. Oncol. 106(4):462-468; 2012.
11. Zhu, X.; Mulcahy, L. A.; Mohammed, R. A.; Lee, A. H.; Franks, H. A.; Kilpatrick, L.; Yilmazer, A.; Paish, E. C.; Ellis, I. O.; Patel, P. M.; Jackson, A. M. IL-17 expression by breast-cancer-associated macrophages: IL-17 promotes invasiveness of breast cancer cell lines. Breast Cancer Res. 10(6):R95; 2008.
12. Zhou, J.; Ding, T.; Pan, W.; Zhu, L. Y.; Li, L.; Zheng, L. Increased intratumoral regulatory T cells are related to intratumoral macrophages and poor prognosis in hepatocellular carcinoma patients. Int. J. Cancer 125(7):1640-1648; 2009.
13. Shen, Z.; Seppanen, H.; Vainionpaa, S.; Ye, Y.; Wang, S.; Mustonen, H.; Puolakkainen, P. IL10, IL11, IL18 are differently expressed in CD14(+) TAMs and play different role in regulating the invasion of gastric cancer cells under hypoxia. Cytokine 59(2):352-357; 2012.
14. Bolat, F.; Kayaselcuk, F. Nursal, T. Z.; Yagmurdur, M. C.; Bal, N.; Demirhan, B. Microvessel density, VEGF expression, and tumor-associated macrophages in breast tumors: Correlations with prognostic parameters. J. Exp. Clin. Cancer Res. 25(3):365-372; 2006.
15. Toge, H.; Inagaki, T.; Kojimoto, Y.; Shinka, T.; Hara, I. Angiogenesis in renal cell carcinoma: The role of tumor-associated macrophages. Int. J. Urol. 16(10):801-807; 2009.
16. Zaidi, M. R.; Merlino, G. The two faces of interferon-gamma in cancer. Clin. Cancer Res. 17(19):6118-6124; 2011.
17. Qin, Z.; Blankenstein, T. CD4+ T cell-mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN gamma receptor expression by nonhematopoietic cells. Immunity 12(6):677-686; 2000.
18. Van Mieghem, N. M.; Nuis, R. J.; Piazza, N. Apostolos, T.; Ligthart, J.; Schultz, C.; de Jaegere, P. P.; Serruys, P. W. Vascular complications with transcatheter aortic valve implantation using the 18 Fr Medtronic CoreValve System: The Rotterdam experience. EuroIntervention 5(6):673-679; 2010.
19. Duluc, D.; Corvaisier, M.; Blanchard, S.; Catala, L.; Descamps, P.; Gamelin, E.; Ponsoda, S.; Delneste, Y.; Hebbar, M.; Jeannin, P. Interferon-gamma reverses the immunosuppressive and protumoral properties and prevents the generation of human tumor-associated macrophages. Int. J. Cancer 125(2):367-373; 2009.
20. Martin-Manso, G.; Galli, S.; Ridnour, L. A.; Tsokos, M.; Wink, D. A.; Roberts, D. D. Thrombospondin 1 promotes tumor macrophage recruitment and enhances tumor cell cytotoxicity of differentiated U937 cells. Cancer Res. 68(17):7090-7099; 2008.
21. Peyregne, V.; Quash, G.; Isaac, S.; Chantepie, J.; Akiba, H.; Scoazec, J. Y.; Gilly, F. N. Survival after gamma interferon intratumoral injections in a model of hepatocarcinoma. Hepatogastroenterology 51(58):1115-1120; 2004.
22. Fujimoto, H.; Sangai, T.; Ishii, G.; Ikehara, A.; Nagashima, T.; Miyazaki, M.; Ochiai, A. Stromal MCP-1 in mammary tumors induces tumor-associated macrophage infiltrationand contributes to tumor progression. Int. J. Cancer 125(6): 1276-1284; 2009.
23. Seta, N.; Kuwana, M. Human circulating monocytes as multipotential progenitors. Keio J. Med. 56(2):41-47; 2007.
24. Werno, C.; Menrad, H.; Weigert, A.; Dehne, N.; Goerdt, S.; Schledzewski, K.; Kzhyshkowska, J.; Brüne, B. Knockout of HIF-1alpha in tumor-associated macrophages enhances M2 polarization and attenuates their pro-angiogenic responses. Carcinogenesis 31(10):1863-1872; 2010.
25. Casneuf, V. F.; Demetter, P.; Boterberg, T.; Delrue, L.; Peeters, M.; Van Damme, N. Antiangiogenic versus cytotoxic therapeutic approaches in a mouse model of pancreatic cancer: An experimental study with a multitarget tyrosine kinase inhibitor (sunitinib), gemcitabine and radiotherapy. Oncol Rep. 22(1):105-113; 2009.
26. Dumont, P.; Berton, A.; Nagy, N.; Sandras, F.; Tinton, S.; Demetter, P.; Mascart, F.; Allaoui, A.; Decaestecker, C.; Salmon, I. Expression of galectin-3 in the tumor immune response in colon cancer. Lab Invest. 88(8):896-906; 2008.
27. Massi, D.; Marconi, C.; Franchi, A.; Bianchini, F.; Paglierani, M.; Ketabchi, S.; Miracco, C.; Santucci, M.; Calorini, L. Arginine metabolism in tumor-associated macrophages in cutaneous malignant melanoma: Evidence from human and experimental tumors. Hum. Pathol. 38(10):1516-1525; 2007.
28. Torroella-Kouri, M.; Silvera, R.; Rodriguez, D.; Caso, R.; Shatry, A.; Opiela, S.; Ilkovitch, D.; Schwendener, R. A.; Iragavarapu-Charyulu, V.; Cardentey, Y.; Strbo, N.; Lopez, D. M. Identification of a subpopulation of macrophages in mammary tumor-bearing mice that are neither M1 nor M2 and are less differentiated. Cancer Res. 69(11):4800-4809; 2009.
29. Kurahara, H.; Shinchi, H.; Mataki, Y.; Maemura, K.; Noma, H.; Kubo, F.; Sakoda, M.; Ueno, S.; Natsugoe, S.; Takao, S. Significance of M2-polarized tumor-associated macrophage in pancreatic cancer. J. Surg. Res. 167(2):e211-219; 2011.
30. Porcheray, F.; Viaud, S.; Rimaniol, A. C.; Leone, C.; Samah, B.; Dereuddre-Bosquet, N.; Dormont, D.; Gras, G. Macrophage activation switching: An asset for the resolution of inflammation. Clin. Exp. Immunol. 142(3):481-489; 2005.
31. Park, E. J.; Ji, K. A.; Jeon, S. B.; Choi, W. H.; Han, I. O.; You, H. J.; Kim, J. H.; Jou, I.; Joe, E. H. Rac1 contributes to maximal activation of STAT1 and STAT3 in IFN-γammastimulated rat astrocytes. J. Immunol. 173(9):5697-5703; 2004.
32. Pietras, E. M.; Miller, L. S.; Johnson, C. T.; O'Connell, R. M.; Dempsey, P. W.; Cheng, G. A MyD88-dependent IFNgammaR-CCR2 signaling circuit is required for mobilization of monocytes and host defense against systemic bacterial challenge. Cell Res. 21(7):1068-1079; 2011.
33. Muller-Quernheim, U. C.; Potthast, L.; Muller-Quernheim, J.; Zissel, G. Tumor-cell co-culture induced alternative activation of macrophages is modulated by interferons in vitro. J Interferon Cytokine Res. 32(4):169-177; 2012.
34. Hagemann, T.; Lawrence, T.; McNeish, I.; Charles, K. A.; Kulbe, H.; Thompson, R. G.; Robinson, S. C.; Balkwill, F. R. "Re-educating" tumor-associated macrophages by targeting NF-kappaB. J. Exp. Med. 205(6):1261-1268; 2008.
35. Kurahara, H.; Takao, S.; Kuwahata, T.; Nagai, T.; Ding, Q.; Maeda, K.; Shinchi, H.; Mataki, Y.; Maenura, K.; Matsuyama, T.; Natsugoe, S. Clinical significance of folate receptor betaexpressing tumor-associated macrophages in pancreatic cancer. Ann. Surg. Oncol. 19(7):2264-2271; 2012.
36. Fong C. H.; Bebien M.; Didierlaurent A.; Nebauer R.; Hussell T.; Broide D.; Karin M.; Lawrence T. An antiinflammatory role for IKKbeta through the inhibition of "classical" macrophage activation. J. Exp. Med. 205(6):1269-1276; 2008.
37. Jeannin P.; Duluc D.; Delneste Y. IL-6 and leukemia-inhibitory factor are involved in the generation of tumor-associated macrophage: Regulation by IFN-γ. Immunotherapy 3(4 Suppl.):23-26; 2011.
38. Lu Y.; Yang W.; Qin C.; Zhang L.; Deng J.; Liu S.; Qin Z. Responsiveness of stromal fibroblastes to IFNgamma blocks tumor growth via angiostasis. J. Immunol. 183(10):6413-6421; 2009.
39. Kommineni V. K.; Nagineni C. N.; William A.; Detrick B.; Hooks J. J. IFN-γamma acts anti-angiogenic cytokine in the human cornea by regulating the expression of VEGF-A and sVEGF-R1. Biochem. Biophys. Res. Commun. 374(3): 479-484; 2008.
40. Demyanets S.; Kaun C.; Rychli K.; Pfaffenberger S.; Kastl S. P.; Hohensinner P. J.; Rega G.; Katsaros K. M.; Afonyushkin T.; Bochkov V. N.; Paireder M.; Huk I.; Maurer G.; Huber K.; Wojta J. Oncostatin M-enhanced vascular endothelial growth factor expression in human vascular smooth muscle cells involves PI3K-, p38 MAPK-, Erk1/2-and STAT1/STAT3-dependent pathways and is attenuated by interferon-γ. Basic Res. Cardiol. 106(2):217-231; 2011.
41. Battle T. E.; Lynch R. A.; Frank D. A. Signal transducer and activator of transcription 1 activation in endothelial cells is a negative regulator of angiogenesis. Cancer Res. 66(7):3649-3657; 2006.